Selin Kurnaz

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Selin Kurnaz

Oct 7, 2024, 12:25 | Blog

Arturo LoAIza-Bonilla: Bringing AI and technology to the forefront of oncology clinical trials at scale

Arturo LoAIza-Bonilla, Co-Founder and Chief Medical Officer of Massive Bio and Medical Director of Oncology…

Sep 18, 2024, 00:05 | Blog

Massive Bio is selected as the Best in Class Quarterfinalist by The Digital Health Hub Foundation

Selin Kurnaz posted on LinkedIn: "Massive Bio is selected as the Best in Class Quarterfinalist…

May 27, 2024, 12:39 | Societies

Selin Kurnaz: Massive Bio and Precision Cancer Consortium's collaborative abstract accepted at ASCO24

Selin Kurnaz, Co-Founder and CEO at Massive Bio, shared on LinkedIn: "I am beyond proud…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023